Search Results - "Lu, Chris X."
-
1
TRAF4 Promotes TGF-β Receptor Signaling and Drives Breast Cancer Metastasis
Published in Molecular cell (12-09-2013)“…TGF-β signaling is a therapeutic target in advanced cancers. We identified tumor necrosis factor receptor-associated factor 4 (TRAF4) as a key component…”
Get full text
Journal Article -
2
USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor
Published in Nature cell biology (01-07-2012)“…The stability and membrane localization of the transforming growth factor-β (TGF-β) type I receptor (TβRI) determines the levels of TGF-β signalling. TβRI is…”
Get full text
Journal Article -
3
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
Published in Proceedings of the National Academy of Sciences - PNAS (26-12-2012)“…Ezh2 (Enhancer of zeste homolog 2) protein is the enzymatic component of the Polycomb repressive complex 2 (PRC2), which represses gene expression by…”
Get full text
Journal Article -
4
Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function
Published in The Journal of biological chemistry (03-06-2011)“…Humans lacking sclerostin display progressive bone overgrowth due to increased bone formation. Although it is well established that sclerostin is an…”
Get full text
Journal Article -
5
RNF12 Controls Embryonic Stem Cell Fate and Morphogenesis in Zebrafish Embryos by Targeting Smad7 for Degradation
Published in Molecular cell (08-06-2012)“…TGF-β members are of key importance during embryogenesis and tissue homeostasis. Smad7 is a potent antagonist of TGF-β family/Smad-mediated responses, but the…”
Get full text
Journal Article -
6
Circulating Cell-Free DNA-Based Detection of Tumor Suppressor Gene Copy Number Loss and Its Clinical Implication in Metastatic Prostate Cancer
Published in Frontiers in oncology (24-08-2021)“…Current liquid biopsy assays lack sufficient sensitivity to detect copy number loss, which limits the interrogation of critical tumor suppressor gene deletions…”
Get full text
Journal Article -
7
Fine-tuning BMP7 signalling in adipogenesis by UBE2O/E2-230K-mediated monoubiquitination of SMAD6
Published in The EMBO journal (03-04-2013)“…SMAD6 is a crucial feedback inhibitory regulator of bone morphogenetic protein (BMP)/SMAD signalling. Although little is known regarding the…”
Get full text
Journal Article -
8
An effective AKT inhibitor-PARP inhibitor combination therapy for recurrent ovarian cancer
Published in Cancer chemotherapy and pharmacology (01-05-2022)“…Background Although the use of PARP inhibitor has received considerable amount of attention in ovarian cancer, PARP inhibitor resistance still emerges with…”
Get full text
Journal Article -
9
Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling
Published in Nature communications (03-03-2014)“…In advanced cancers, the TGF-β pathway acts as an oncogenic factor and is considered to be a therapeutic target. Here using a genome-wide cDNA screen, we…”
Get full text
Journal Article -
10
Rescue screens with secreted proteins reveal compensatory potential of receptor tyrosine kinases in driving cancer growth
Published in Cancer discovery (01-10-2012)“…The overall power of kinase inhibitors is substantially overshadowed by the acquisition of drug resistance. To address this issue, we systematically assessed…”
Get more information
Journal Article -
11
RNF12 Controls Embryonic Stem Cell Fate and Morphogenesis in Zebrafish Embryos by Targeting Smad7 for Degradation
Published in Molecular cell (27-07-2012)Get full text
Journal Article -
12
USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-[beta] type I receptor
Published in Nature cell biology (01-07-2012)“…The stability and membrane localization of the transforming growth factor-[beta] (TGF-[beta]) type I receptor (T[beta]RI) determines the levels of TGF-[beta]…”
Get full text
Journal Article -
13
Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-[beta] signalling
Published in Nature communications (01-03-2014)“…In advanced cancers, the TGF-β pathway acts as an oncogenic factor and is considered to be a therapeutic target. Here using a genome-wide cDNA screen, we…”
Get full text
Journal Article